Summarizing, while current biological therapy which presumably seeks to target specific immune and biochemical abnormalities at the molecular and cellular level, the stable gastric pentadecapeptide BPC 157 evidence is more general, and from this point of view, even more suited for additional applications
Our Spring/Summer Transformation Special is in its final weeks, and there has never been a better time to finish your look
Their inclusion makes Glutone-A a valuable addition to a balanced lifestyle focused on beauty and wellness
ATLANTA Health care professionals may improve access to obesity medications for adolescents through a specialty pharmacy partnership, according to a presenter at ObesityWeek
[PubMed] AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to RekyndaTM (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder AMAG Pharmaceuticals.